Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
36.7%
% of MEDX's 30 holdings also in XLV
18.0%
% of XLV's 61 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus XLV)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in XLV |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.7% | 12.3% | 12.3% |
|
ABBVIE INC | 9.6% | 6.9% | 6.9% |
|
JOHNSON & JOHNSON | 5.0% | 7.4% | 5.0% |
|
MERCK & CO. INC. | 3.7% | 4.4% | 3.7% |
|
AMGEN INC | 6.3% | 3.2% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to XLV
 |
NOVARTIS AG-ADR | 6.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.5% |
|
ALNYLAM PHARMACEUTICALS INC | 4.8% |
 |
ALKERMES PLC | 4.7% |
|
ELI LILLY & CO | 4.3% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% |
|
AMGEN INC | 3.1% |
|
ABBVIE INC | 2.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.6% |
|
CRISPR THERAPEUTICS AG | 2.6% |
MEDX Underweight Relative to XLV
|
UNITEDHEALTH GROUP INC | -8.9% |
|
ABBOTT LABORATORIES | -4.1% |
|
THERMO FISHER SCIENTIFIC INC | -3.7% |
|
INTUITIVE SURGICAL INC | -3.3% |
|
BOSTON SCIENTIFIC CORP | -2.8% |
|
DANAHER CORP | -2.5% |
|
GILEAD SCIENCES INC | -2.5% |
|
VERTEX PHARMACEUTICALS INC | -2.4% |
|
JOHNSON & JOHNSON | -2.4% |
|
STRYKER CORP | -2.4% |